Pacira | PCRX - Ebitda





Ebitda Changement Date
Astellas Pharma JPY 182.02B 53.22B 2026-09
Bristol-Myers Squibb USD 3.48B 1.6B 2026-09
Cara Therapeutics USD -2.39M 3.16M 2025-03
Coherus Biosciences USD -43.33M 4.7M 2025-09
Heron Therapeutics USD -3.88M 5.63M 2024-09
Ironwood Pharmaceuticals USD 81.81M 31.71M 2025-09
J&J USD 8.99B 721M 2026-06
Ligand Pharmaceuticals USD 74.27M 88.56M 2026-06
Nektar Therapeutics USD -38.9M 7.09M 2026-03
Novo Nordisk DKK 37.36B 2.64B 2026-06
Omeros USD -47.96M 7.39M 2023-09
Pacira USD 48.67M 8.43M 2026-06
Perrigo USD 156.6M 83M 2026-09
Pfizer USD 6.36B 350M 2026-09
Supernus Pharmaceuticals USD 55.6M 24M 2026-09
Teva Pharmaceutical Industries USD 1.5B 1.02B 2026-09
Xeris Pharmaceuticals USD -20.94M 33.27M 2026-06
Zoetis USD 1.07B 21M 2026-09